D.R.I.V.E. is a strategic framework for promoting representative enrollment in clinical trials. D.R.I.V.E. addresses safety and efficacy concerns that arise when studies are conducted in populations that do not reflect the different patient groups that treatments are intended to serve. Join Maya Birhiray, medical science liaison, to learn more about this initiative and its importance in clinical trials.
HealthTree Resources:
Indy Hematology Education Resources:
Let me know your thoughts on today's episode! Please share them in a comment or reach out anytime at hannah@healthtree.org.